Trying to separate three different claims about cardarine: that it is the right molecule, that it is the right dose, and that it does something useful.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
What the SARM class does pharmacologically does not require the subjective effect to be large to be real.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Lipids move and nobody checks them, which is why SARMs have a reputation for being harmless.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Baseline first. Without a baseline the after picture is decoration.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial. Not on cardarine but the pattern is familiar.
Baseline first. Without a baseline the after picture is decoration.
A certificate of analysis answers one question and gets quoted as though it answers four.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation. How long have you been on cardarine?
Narrow conclusion.
Same here.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.